Merck has agreed to acquire biotechnology company Pandion Therapeutics for approximately $1.85bn to expand its portfolio of autoimmune disease-targeting candidates.
Pfizer and BioNTech have dosed the first participants in a global Phase II / III study of their vaccine in preventing Covid-19 in healthy pregnant women aged 18 and above.
Johnson & Johnson’s (J&J) Janssen-Cilag International has announced it applied to the European Medicines Agency (EMA) to obtain authorisation for its Covid-19 vaccine candidate.
The World Health Organization (WHO) has granted Emergency Use Listing (EUL) to AstraZeneca’s Covid-19 vaccine for active immunisation to prevent the disease in adults, including those aged above 65 years.
The Qatar Ministry of Public Health has granted an emergency use authorisation (EUA) to biotechnology company Moderna’s Covid-19 vaccine.